Appendix 3Y Change of Director’s Interest Notice + See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1 Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and...
Change of Director's Interest Notice - DH
Filed with ASX · · 4 pages · English
Release
Algorae Pharmaceuticals Limited on 6ix
Earlier from Algorae Pharmaceuticals
- Date of AGM and Closing Date for Director Nominations
- Notification of cessation of securities - 1AI
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- Quarterly Activities Report/Appendix 4C Cashflow Statement
Later from Algorae Pharmaceuticals
- Notice of Annual General Meeting/Proxy Form
- Peter Mac partners with Algorae on 3rd AI validation program
- Algorae executes Licence & Supply Agreement with Umedica
- Updated Securities Trading Policy
- Quarterly Activities Report and Appendix 4C Cash Flow Report
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals